This represents a positive trend in reducing the chances of pain medication overuse and the risk of adverse effects.
← all excerpts
Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive Medications.
1
—
—